Devyser Diagnostics
78.10 SEK
-0.13 %
Less than 1K followers
DVYSR
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Devyser Diagnostics
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | 93.5 | 126.6 | 169.3 | 216.9 | 250.5 |
| growth-% | 35.4 % | 33.7 % | 28.1 % | 15.5 % | |
| EBITDA | -21.2 | -43.4 | 45.8 | -51.0 | 37.2 |
| EBIT | -21.2 | -52.0 | -58.9 | -58.3 | 10.1 |
| Profit before taxes | -21.9 | -52.7 | -54.4 | -57.6 | -2.6 |
| Net income | -20.7 | -46.0 | -53.6 | -61.5 | -8.4 |
| EPS | -1.85 | -2.89 | -3.31 | -3.75 | -0.51 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | -0.0 % | -0.0 % |
Profitability and return on capital
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| EBITDA-% | -22.7 % | -34.3 % | 27.1 % | -23.5 % | 14.9 % |
| EBIT-% | -22.7 % | -41.1 % | -34.8 % | -26.9 % | 4.0 % |
| ROE | -5.0 % | -10.7 % | -13.9 % | -17.6 % | -2.4 % |
| ROI | -4.5 % | -9.2 % | -10.5 % | -13.0 % | -1.8 % |